Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation
Complement Therapeutics has announced that CTx001, its gene therapy for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), has ...
Read moreDetails

















